MEDIVATION, INC. 4

Accession 0001209191-16-143396

CIK 0001011835operating

Filed

Sep 29, 8:00 PM ET

Accepted

Sep 30, 5:59 PM ET

Size

25.4 KB

Accession

0001209191-16-143396

Form 4

Period: 2016-09-28

Director

Transactions

Disposition from Tender
Common Stock
2016-09-28−15,000→ 0 total(indirect: By Trust)
Disposition to Issuer
Non-Qualified Stock Option (right to buy)
2016-09-28−30,000→ 0 total
Exercise: $23.74Exp: 2022-07-16→ Common Stock (30,000 underlying)
Disposition to Issuer
Non-Qualified Stock Option (right to buy)
2016-09-28−6,284→ 0 total
Exercise: $55.45Exp: 2025-06-16→ Common Stock (6,284 underlying)
Disposition to Issuer
Non-Qualified Stock Option (right to buy)
2016-09-28−6,228→ 0 total
Exercise: $58.89Exp: 2026-06-22→ Common Stock (6,228 underlying)
Disposition to Issuer
Non-Qualified Stock Option (right to buy)
2016-09-28−60,000→ 0 total
Exercise: $5.50Exp: 2021-07-15→ Common Stock (60,000 underlying)
Disposition from Tender
Common Stock
2016-09-28−17,742→ 0 total
Disposition to Issuer
Non-Qualified Stock Option (right to buy)
2016-09-28−12,232→ 0 total
Exercise: $24.60Exp: 2023-06-28→ Common Stock (12,232 underlying)
Disposition to Issuer
Non-Qualified Stock Option (right to buy)
2016-09-28−9,584→ 0 total
Exercise: $38.89Exp: 2024-06-27→ Common Stock (9,584 underlying)
Disposition to Issuer
Non-Qualified Stock Option (right to buy)
2016-09-28−60,000→ 0 total
Exercise: $5.60Exp: 2019-06-30→ Common Stock (60,000 underlying)
Disposition to Issuer
Non-Qualified Stock Option (right to buy)
2016-09-28−60,000→ 0 total
Exercise: $2.21Exp: 2020-06-30→ Common Stock (60,000 underlying)

Footnotes (3)

[F1]Disposed of pursuant to an Agreement and Plan of Merger (the "Merger Agreement"), dated August 20, 2016, among the Issuer, Pfizer Inc., a Delaware corporation ("Parent"), and Montreal, Inc., a Delaware corporation and a wholly-owned subsidiary of Parent ("Purchaser"), in exchange for a cash consideration of $81.50 per share (without interest) subject to any required withholding of taxes. Pursuant to the Merger Agreement, the Purchaser merged with and into the Issuer, with the Issuer surviving as a wholly-owned subsidiary of Parent (the "Merger"). In connection with the Merger, Purchaser offered to purchase all of the outstanding shares of common stock, par value $0.01 per share of the Issuer, at a price of $81.50 per share, net to the seller in cash (without interest) but subject to any required withholding of taxes, upon the terms and conditions set forth in the offer to purchase dated August 30, 2016, and in the related letter of transmittal.
[F2]Includes 2,972 unvested shares subject to a restricted stock award.
[F3]This option was cancelled in the Merger in exchange for a cash payment equal to $81.50 per share (without interest) subject to any required withholding of taxes minus the per share exercise price of the option. In connection with the Merger, vesting of the option was accelerated and the option became fully vested and exercisable effective immediately prior to the effective time of the Merger.

Documents

1 file

MEDIVATION, INC.

CIK 0001011835

Entity typeoperating

IncorporatedDE